SciELO - Scientific Electronic Library Online

 
vol.74 número2Vocación médica: necesidad de su estudio científicoÁntrax cutáneo complicado con fascitis necrotizante y síndrome compartimental índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Anales de la Facultad de Medicina

versão impressa ISSN 1025-5583

Resumo

SOSA ROSADO, José Manuel. New oral anticoagulants in thromboembolism prevention in nonvalvular atrial fibrillation. An. Fac. med. [online]. 2013, vol.74, n.2, pp.139-144. ISSN 1025-5583.

Atrial fibrillation is the most frequent cardiac arrhythmia in clinical practice. The value of anticoagulation with vitamin K antagonists like warfarin in the prevention of embolic phenomena is widely demonstrated but managing is difficult because of its known interactions with other drugs and even food. Looking for the ideal anticoagulant in the last years new antithrombotic agents have appeared and others are in advanced phases of investigation. In the current review results of new anticoagulant agents development and expectations, opportunities and challenges are described in regards to direct thrombin and Xa factor inhibitors.

Palavras-chave : Atrial fibrillation; warfarin; direct thrombin inhibitors; direct factor Xa inhibitors.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )